We are live on ! Find out more
AP

Antipodes Partners Portfolio holdings

AUM $5.46B
1-Year Est. Return 26.64%
This Fund
S&P 500
This Quarter Est. Return
+9.77%
1 Year Est. Return
+26.64%
3 Year Est. Return
+96.4%
5 Year Est. Return
+160.76%
10 Year Est. Return
–
AUM
$4.46B
AUM Growth
+$1.23B
Cap. Flow
+$904M
Cap. Flow %
20.28%
Top 10 Hldgs %
37.6%
Holding
139
New
33
Increased
39
Reduced
42
Closed
23

Top Buys

Rank Stock Value
1
FER icon
Ferrovial N.V. Ordinary Shares
FER
+$167M
2
EXC icon
Exelon
EXC
+$156M
3
AEE icon
Ameren
AEE
+$137M
4
SRE icon
Sempra
SRE
+$136M
5
CCI icon
Crown Castle
CCI
+$128M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$108M
2
MSFT icon
Microsoft
MSFT
+$91.6M
3
B
Barrick Mining
B
+$63.5M
4
JCI icon
Johnson Controls International
JCI
+$58.9M
5
COF icon
Capital One
COF
+$53.6M

Sector Composition

Rank Sector Weight
1 Utilities 29.08%
2 Healthcare 12.43%
3 Technology 11.96%
4 Financials 8.08%
5 Materials 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRKR icon
76
Bruker
BRKR
$8.58B
$265K 0.01%
8,168
+1,380
+20% +$49.2K
MNDY icon
77
monday.com
MNDY
$3.75B
$252K 0.01%
+1,303
New +$300K
ARGX icon
78
argenx
ARGX
$54.2B
$212K ﹤0.01%
287
-45
-14% -$29.7K
TDW icon
79
Tidewater
TDW
$4.46B
$179K ﹤0.01%
+3,362
New +$184K
PUBM icon
80
PubMatic
PUBM
$809M
$158K ﹤0.01%
+19,065
New +$194K
CERT icon
81
Certara
CERT
$1.23B
$150K ﹤0.01%
12,285
+5,620
+84% +$61.5K
IMNM icon
82
Immunome
IMNM
$2.91B
$128K ﹤0.01%
10,892
+631
+6% +$6.28K
GPCR icon
83
Structure Therapeutics
GPCR
$3.82B
$114K ﹤0.01%
4,078
+1,146
+39% +$22.8K
ABT icon
84
Abbott
ABT
$188B
$111K ﹤0.01%
828
+87
+12% +$11.4K
CHYM
85
Chime Financial
CHYM
$11.7B
$109K ﹤0.01%
5,402
+402
+8% +$11.4K
DXCM icon
86
DexCom
DXCM
$33.1B
$109K ﹤0.01%
1,617
+773
+92% +$61.2K
SDGR icon
87
Schrodinger
SDGR
$1.4B
$98.5K ﹤0.01%
4,912
+3,660
+292% +$73.5K
STE icon
88
Steris
STE
$23.3B
$87.1K ﹤0.01%
352
+92
+35% +$22K
COR icon
89
Cencora
COR
$62B
$83.1K ﹤0.01%
266
+62
+30% +$18.2K
RIG icon
90
Transocean
RIG
$6.33B
$77.5K ﹤0.01%
+24,838
New +$74.9K
QGEN icon
91
Qiagen
QGEN
$9.04B
$68.2K ﹤0.01%
1,526
-1,040
-41% -$49.8K
MYRG icon
92
MYR Group
MYRG
$5.14B
$62.6K ﹤0.01%
301
-403
-57% -$75.2K
ESTA icon
93
Establishment Labs
ESTA
$2.21B
$53.6K ﹤0.01%
1,307
-741
-36% -$30.3K
NTRA icon
94
Natera
NTRA
$45.9B
$53.1K ﹤0.01%
330
+17
+5% +$2.69K
TMO icon
95
Thermo Fisher Scientific
TMO
$222B
$47.5K ﹤0.01%
+98
New +$45.6K
MASS icon
96
908 Devices
MASS
$361M
$45.8K ﹤0.01%
5,227
-1,331
-20% -$8.84K
HSIC icon
97
Henry Schein
HSIC
$9.82B
$41.9K ﹤0.01%
632
+46
+8% +$3.18K
GE icon
98
GE Aerospace
GE
$380B
$41.2K ﹤0.01%
137
-94
-41% -$25.7K
IR icon
99
Ingersoll Rand
IR
$33.6B
$40.2K ﹤0.01%
486
+173
+55% +$14.2K
IRTC icon
100
iRhythm Holdings
IRTC
$4.1B
$37.8K ﹤0.01%
220
-35
-14% -$5.56K
2 3
4
5 6

Similar funds

DWA
Douglass Winthrop Advisors New York $5.46B AUM 11.49% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
LP
Linonia Partnership New York $5.38B AUM 20.54% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
WL
WIT LLC District Of Columbia, District of Columbia $5.3B AUM 20.46% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

Antipodes Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Antipodes Partners held 139 positions worth $4.46B, up 38% from $3.22B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Antipodes Partners deployed $904M of net new capital in Q3 2025, opening 33 new positions and adding to 39 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 3,097,701 shares worth $176M.

By sector, the portfolio is most concentrated in Utilities at 29% of assets, up from 3.7% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $108M trimmed.

  • Antipodes Partners's largest Q3 2025 buy was Ferrovial N.V. Ordinary Shares: 3,097,701 shares worth $176M.
  • Antipodes Partners added most to Exelon in Q3 2025, an estimated $156M increase.
  • Antipodes Partners's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $108M.
  • Antipodes Partners fully exited Micron Technology in Q3 2025, selling an estimated $49.7M.
  • Antipodes Partners's ten largest holdings make up 38% of its $4.46B portfolio in Q3 2025.
  • Antipodes Partners opened 33 new positions and closed 23 in Q3 2025.
  • Antipodes Partners's portfolio value rose 38% quarter-over-quarter to $4.46B.

Based on Antipodes Partners's 13F filing for Q3 2025, filed 10 Nov 2025.